Top

Published in:

01-12-2012 | Pediatric Allergy and Immunology (JM Portnoy and CE Ciaccio, Section Editors)

Current Strategies in Treating Severe Contact Dermatitis in Pediatric Patients

Authors: Luz S. Fonacier, Marcella R. Aquino, Tania Mucci

Published in: Current Allergy and Asthma Reports | Issue 6/2012

Abstract

Allergic contact dermatitis in children is underdiagnosed and undertreated, and its incidence is increasing. Appropriate history taking and the suspicion for allergic contact dermatitis is essential, and patch testing remains the gold standard in diagnosis. Avoidance of the offending allergen, once identified, is the first goal of treatment. Medical therapies include topical corticosteroid and topical immunomodulators. In severe cases, oral corticosteroids or immunomodulators are utilized, although prospective randomized trials for the treatment of this disease in children are lacking. A PubMed literature search was performed to identify publications on allergic contact dermatitis in the pediatric population with the keywords: dermatitis, children, allergic contact dermatitis, pediatrics, contact hypersensitivity, contact allergy, treatment, and management. This review will address the major principles behind the diagnosis and management of this disease in the pediatric population, and highlight useful strategies that may result in improved treatment of this condition.

Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490–500.PubMedCrossRef

Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18(4):385–90.PubMedCrossRef

Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children–a United States based study. Pediatr Dermatol. 2008;25(5):520–7.PubMedCrossRef

Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514–20.PubMedCrossRef

Kutting B, Brehler R, Traupe H. Allergic contact dermatitis in children: strategies of prevention and risk management. Eur J Dermatol. 2004;14(2):80–5.PubMed

Giordano-Labadie F, Rance F, Pellegrin F, Bazex J, Dutau G, Schwarze HP. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis. 1999;40(4):192–5.PubMedCrossRef

• Herro EM, Matiz C, Sullivan K, Hamann C, Jacob SE. Frequency of contact allergens in pediatric patients with atopic dermatitis. J Clin Aesthet Dermatol. 2011;4(11):39-41. Retrospective chart review, suggesting that patch testing is indicated in children with moderate-to severe atopic dermatitis. PubMed

Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol. 2001;144(3):523–32.PubMedCrossRef

Goebeler M, Trautmann A, Voss A, Brocker EV, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol. 2001;158(2):431–40.PubMedCrossRef

10.

Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol. 2004;14(3):131–8.PubMed

11.

Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis. 2008;58(3):188–9.PubMedCrossRef

12.

Astner S, Gonzalez E, Cheung AC, et al. Non-invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J Invest Dermatol. 2005;124(2):351–9.PubMedCrossRef

13.

Brasch J, Burgard J, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol. 1992;98(2):166–70.PubMedCrossRef

14.

• Belloni Fortina A, Romano I, Peserico A, Eichenfield LF. Contact sensitization in very young children. J Am Acad Dermatol. 2011;65(4):772-779. 321 children aged 3-36 months underwent patch testing for suspected allergic contact dermatitis. A high prevalence of contact sensitization was found in toddlers younger than 3 years of age. Allergic contact dermatitis should be considered in this population. PubMedCrossRef

15.

Litvinov IV, Sugathan P, Cohen BA. Recognizing and treating toilet-seat contact dermatitis in children. Pediatrics. 2010;125(2):e419–22.PubMedCrossRef

16.

Matiz C, Jacob SE. Systemic contact dermatitis in children: how an avoidance diet can make a difference. Pediatr Dermatol. 2011;28(4):368–74.PubMedCrossRef

17.

Seidenari S, Giusti F, Pepe P, Mantovani L. Contact sensitization in 1094 children undergoing patch testing over a 7-year period. Pediatr Dermatol. 2005;22(1):1–5.PubMedCrossRef

18.

Champion RH, Rook A, Wilkinson DS, Ebling FJG. Rook/Wilkinson/Ebling textbook of dermatology. 6th ed. Oxford Malden, MA: Blackwell Science; 1998.

19.

Contact dermatitis: a practice parameter. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2006;97(3 Suppl 2):S1-38.

20.

• Bonitsis NG, Tatsioni A, Bassioukas K, Ioannidis JP. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis. May 2011;64(5):245-257. Meta-analysis to evaluate the proportion of positive reactions for allergens tested in children, offering guidance on relevant contact allergens in the pediatric population. PubMedCrossRef

21.

Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis. 2004;51(3):111–7.PubMedCrossRef

22.

Rycroft RJG. Textbook of contact dermatitis. 3rd ed. Berlin New York: Springer; 2001.

23.

Fernandez Vozmediano JM, Armario Hita JC. Allergic contact dermatitis in children. J Eur Acad Dermatol Venereol. 2005;19(1):42–6.PubMedCrossRef

24.

Larsson-Stymne B, Widstrom L. Ear piercing–a cause of nickel allergy in schoolgirls? Contact Dermatitis. 1985;13(5):289–93.PubMedCrossRef

25.

Rystedt I, Fischer T. Relationship between nickel and cobalt sensitization in hard metal workers. Contact Dermatitis. 1983;9(3):195–200.PubMedCrossRef

26.

Dotterud LK, Falk ES. Metal allergy in north Norwegian schoolchildren and its relationship with ear piercing and atopy. Contact Dermatitis. 1994;31(5):308–13.PubMedCrossRef

27.

Christensen OB, Moller H. Nickel allergy and hand eczema. Contact Dermatitis. 1975;1(3):129–35.PubMedCrossRef

28.

Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol. 1993;29(6):1002–7.PubMedCrossRef

29.

Antico A, Soana R. Chronic allergic-like dermatopathies in nickel-sensitive patients. Results of dietary restrictions and challenge with nickel salts. Allergy Asthma Proc. 1999;20(4):235–42.PubMedCrossRef

30.

Sharma AD. Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol. 2007;73(5):307–12.PubMedCrossRef

31.

Belsito DV. Thimerosal: contact (non)allergen of the year. Am J Contact Dermat. 2002;13(1):1–2.PubMedCrossRef

32.

van’t Veen AJ. Vaccines without thiomersal: why so necessary, why so long coming? Drugs. 2001;61(5):565–72.PubMedCrossRef

33.

Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232–5.PubMedCrossRef

34.

Trattner A, David M. Patch testing with fine fragrances: comparison with fragrance mix, balsam of Peru and a fragrance series. Contact Dermatitis. 2004;49(6):287–9.PubMedCrossRef

35.

Larsen W, Nakayama H, Lindberg M, et al. Fragrance contact dermatitis: a worldwide multicenter investigation (Part I). Am J Contact Dermat. 1996;7(2):77–83.PubMedCrossRef

36.

Zug KA, Warshaw EM, Fowler Jr JF, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009;20(3):149–60.PubMed

37.

Hjorth N. Eczematous allergy to balsams, allied perfumes and flavouring agents, with special reference to balsam of Peru. Acta Derm Venereol Suppl (Stockh). 1961;41 Suppl 46:1–216.

38.

Bedello PG, Goitre M, Cane D. Contact dermatitis and flare from food flavouring agents. Contact Dermatitis. 1982;8(2):143–4.PubMedCrossRef

39.

Salam TN, Fowler Jr JF. Balsam-related systemic contact dermatitis. J Am Acad Dermatol. 2001;45(3):377–81.PubMedCrossRef

40.

Veien NK, Hattel T, Justesen O, Norholm A. Reduction of intake of balsams in patients sensitive to balsam of Peru. Contact Dermatitis. 1985;12(5):270–3.PubMedCrossRef

41.

Veien NK, Hattel T, Justesen O, Norholm N. Oral challenge with balsam of Peru. Contact Dermatitis. 1985;12(2):104–7.PubMedCrossRef

42.

Fisher AA, Rietschel RL, Fowler JF. Fisher’s contact dermatitis. 6th ed. Hamilton: BC Decker Inc.; 2008.

43.

Bjarnason B, Flosadottir E. Patch testing with neomycin sulfate. Contact Dermatitis. 2000;43(5):295–302.PubMedCrossRef

44.

De U, Pal DK. Seventy cases of non-tubercular psoas abscess at a rural referral centre in South Bengal. Tropical doctor. 2006;36(1):53–4.PubMedCrossRef

45.

Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy. Am J Dis Child. 1993;147(2):128–9.PubMed

46.

Paulsen E, Otkjaer A, Andersen KE. Sesquiterpene lactone dermatitis in the young: is atopy a risk factor? Contact Dermatitis. 2008;59(1):1–6.PubMedCrossRef

47.

Belloni Fortina A, Romano I, Peserico A. Contact sensitization to Compositae mix in children. J Am Acad Dermatol. 2005;53(5):877–80.PubMedCrossRef

48.

Beattie PE, Green C, Lowe G, Lewis-Jones MS. Which children should we patch test? Clin Exp Dermatol. 2007;32(1):6–11.PubMed

49.

Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis. 2011;22(4):204–10.PubMed

50.

Camacho-Halili M, Axelrod S, Michelis MA, et al. A multi-center, retrospective review of patch testing for contact dermatitis in allergy practices. Ann Allergy Asthma Immunol. 2011;107(6):487–92.PubMedCrossRef

51.

Davis MD, Bhate K, Rohlinger AL, Farmer SA, Richardson DM, Weaver AL. Delayed patch test reading after 5 days: the Mayo Clinic experience. J Am Acad Dermatol. 2008;59(2):225–33.PubMedCrossRef

52.

Corazza M, Baldo F, Ricci M, Sarno O, Virgili A. Efficacy of new barrier socks in the treatment of foot allergic contact dermatitis. Acta Derm Venereol. 2011;91(1):68–9.PubMed

53.

•• Fonacier LSMB. Contact Dermatitis: Elsevier Saunders; 2010. In depth reference on ACD in children with extensive discussion on pathogenesis, relevant allergens, diagnosis, and treatment.

54.

Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118(1):152–69.PubMedCrossRef

55.

Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology. 2007;215 Suppl 1:45–54.PubMedCrossRef

56.

Bekersky I, Fitzsimmons W, Tanase A, Maher RM, Hodosh E, Lawrence I. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol. 2001;44(1 Suppl):S17–27.PubMedCrossRef

57.

Belsito D, Wilson DC, Warshaw E, et al. A prospective randomized clinical trial of 0.1 % tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40–6.PubMedCrossRef

58.

Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1 % vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192–6.PubMed

59.

Mrowietz U, Klein CE, Reich K, et al. Cyclosporine therapy in dermatology. J Dtsch Dermatol Ges. 2009;7(5):474–9.PubMed

60.

Heller M, Shin HT, Orlow SJ, Schaffer JV. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol. 2007;157(1):127–32.PubMedCrossRef

61.

Simon D. Systemic therapy of atopic dermatitis in children and adults. Curr Probl Dermatol. 2011;41:156–64.PubMedCrossRef

62.

Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol. 1998;78(1):40–3.PubMedCrossRef

63.

Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. 2006;72(1):24–7.PubMedCrossRef

64.

Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371–6.PubMed

65.

Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat. 2009;20(3):141–5.PubMedCrossRef

66.

Brandao MH, Gontijo B, Girundi MA, de Castro MC. Ear piercing as a risk factor for contact allergy to nickel. J Pediatr (Rio J). 2010;86(2):149–54.CrossRef

67.

Jensen CS, Lisby S, Baadsgaard O, Volund A, Menne T. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br J Dermatol. 2002;146(4):636–42.PubMedCrossRef

68.

Thyssen JP. Nickel and cobalt allergy before and after nickel regulation–evaluation of a public health intervention. Contact Dermatitis. 2011;65 Suppl 1:1–68.CrossRef

69.

Corrente S, Moschese V, Chianca M, et al. Temporary henna tattoo is unsafe in atopic children. Acta Paediatrica. 2007;96(3):469–71.PubMedCrossRef

70.

Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, Eichenfield LF. p-Phenylenediamine in black henna tattoos: a practice in need of policy in children. Arch Pediatr Adolesc Med. 2008;162(8):790–2.PubMedCrossRef

71.

DeLeo VA. p-Phenylenediamine. Dermatitis. 2006;17(2):53–5.PubMed

Title: Current Strategies in Treating Severe Contact Dermatitis in Pediatric Patients
Authors: Luz S. Fonacier
Marcella R. Aquino
Tania Mucci
Publication date: 01-12-2012
Publisher: Current Science Inc.
Published in: Current Allergy and Asthma Reports / Issue 6/2012
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI: https://doi.org/10.1007/s11882-012-0305-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Current Strategies in Treating Severe Contact Dermatitis in Pediatric Patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

Innovations in Technology: Social Media and Mobile Technology in the Care of Adolescents with Asthma

Otitis Media in Infancy and the Development of Asthma and Atopic Disease

Current Knowledge of the Genetics of Otitis Media

Treatment of Acute Otitis Media in Young Children

IgE-Mediated Cow’s Milk Allergy in Children

Cellular Targeting in Autoimmunity